Congenital absence of nitric oxide synthase 3 potentiates cardiac dysfunction and reduces survival in doxorubicin- and trastuzumab-mediated cardiomyopathy.
| Image |  |
|---|---|
| Description | scientific article published on 16 November 2013 |
| Author/s |
author: Davinder S Jassal Matthew Zeglinski |
| Publication date | November 16, 2013 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |